MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Spinal fluid biomarkers for multiple system atrophy – A pilot study

    W. Singer, A. Schmeichel, D.M. Goldstein, J.D. Schmelzer, A.D. Zeller, T.L. Gehrking, P.A. Low (Rochester, MN, USA)

    Objective: To evaluate a comprehensive panel of cerebral spinal fluid (CSF) markers in multiple system atrophy (MSA) to define those with potential as future disease…
  • 2016 International Congress

    J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms

    T. Maeda, Y. Shimo, S.W. Chiu, T. Yamaguchi, K. Kashihara, Y. Tsuboi, M. Nomoto, N. Hattori, H. Watanabe, H. Saiki (Akita, Japan)

    Objective: To clarify the clinical manifestations of nonmotor symptoms (NMSs) and identify factors affecting NMSs and quality of life (QOL) in Japanese patients with Parkinson's…
  • 2016 International Congress

    The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations

    S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)

    Objective: The aim of this study was to investigate the relationship between cognitive phenotype and 5-HT2A receptor availability in PD patients with visual hallucinations (VH).…
  • 2016 International Congress

    Cognition, vision and visuo-cognition in gait in Parkinson’s disease

    S. Stuart, B. Galna, S. Lord, L. Rochester (Newcastle upon Tyne, United Kingdom)

    Objective: This study examined the selective but overlapping roles of cognition and vision in gait in Parkinson's disease (PD). To address this we studied; 1)…
  • 2016 International Congress

    Higher doses of dopamine agonists, impulse control disorders and history of deep brain stimulation (DBS): Risk factors for dopamine agonists withdrawal syndrome (DAWS)?

    X. Garcia, S. Patel, M.E. Mohammad, X.X. Yu, K. Sutton, K. O'Donnell, H. Fernandez (Cleveland, OH, USA)

    Objective: To identify risk factors in the development of DAWS in patients with Parkinson's disease (PD). Background: DAWS is often a severe, stereotyped cluster of…
  • 2016 International Congress

    The relation between dream content and non-motor symptoms in Parkinson’s disease and idiopathic REM sleep behavior disorder

    P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

    Objective: Assess the relation between dream content and non-motor symptoms in Parkinson's disease (PD) and idiopathic REM sleep behavior disorder (iRBD). Background: Although a link…
  • 2016 International Congress

    Sleep deprivation (SD) amongst carers of patients with Parkinson’s disease (PD)

    D. Kulatunga, H. Avery, A.K. Chatterjee, A. Plowman, J. Caffrey, S. Pradhan (Reading, United Kingdom)

    Objective: To identify nocturnal symptoms in patients which lead to sleep deprivation in carers of PD patients. Background: SD affects the health status of the…
  • 2016 International Congress

    Non-motor symptoms (NMS) as a determinant of caregiver burden in a cohort of older patients with Parkinson’s disease (PD)

    S. Gangadharan, N. Bareham, A. Johnson, M. Rees, A. Withenage, C.P. Padmakumar (Newcastle, Australia)

    Objective: The main goal of this study was to assess the impact of NMS burden and severity on Caregiver Burden in a cohort of older…
  • 2016 International Congress

    Non-motor symptoms in a PPMI cohort of p.A53T α-synuclein mutation-related and sporadic Parkinson’s disease patients

    C. Koros, M. Stamelou, I. Beratis, N. Papagiannakis, A.M. Simitsi, D. Papadimitriou, S. Fragiadaki, D. Kontaxopoulou, S.G. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: To evaluate the prevalence of non-motor symptoms in p.A53T α-synuclein (SNCA) related Parkinson's disease (PD) as compared to sporadic Parkinson's disease (sPD) patients. Background:…
  • 2016 International Congress

    Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2

    K. Suzuki, A. Numao, T. Kadowaki, S. Suzuki, Y. Watanabe, M. Miyamoto, T. Miyamoto, T. Uchiyama, K. Hashimoto, H. Fujita, Y. Watanabe, T. Matsubara, K. Hirata (Mibu, Japan)

    Objective: To evaluate the relationship between fatigue and sleep disturbances in patients with Parkinson's disease (PD). Background: In patients with PD, fatigue is an important…
  • « Previous Page
  • 1
  • …
  • 1553
  • 1554
  • 1555
  • 1556
  • 1557
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley